Literature DB >> 15211093

Pathogenesis of hypertension in diabetes.

Sameer N Stas1, Fadi A El-Atat, James R Sowers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15211093     DOI： 10.1023/B:REMD.0000032410.75638.da

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN： 1389-9155            Impact factor:   6.514


× No keyword cloud information.
  45 in total

Review 1.  Insulin resistance and cardiovascular disease.

Authors:  S I McFarlane; M Banerji; J R Sowers
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

2.  Hyperinsulinaemia is not linked with blood pressure elevation in patients with insulinoma.

Authors:  P T Sawicki; L Heinemann; A Starke; M Berger
Journal:  Diabetologia       Date:  1992-07       Impact factor: 10.122

Review 3.  Diabetes, hypertension, and cardiovascular disease: an update.

Authors:  J R Sowers; M Epstein; E D Frohlich
Journal:  Hypertension       Date:  2001-04       Impact factor: 10.190

4.  Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man.

Authors:  J W Rowe; J B Young; K L Minaker; A L Stevens; J Pallotta; L Landsberg
Journal:  Diabetes       Date:  1981-03       Impact factor: 9.461

5.  Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in type 1 (insulin-dependent) diabetes mellitus.

Authors:  B Feldt-Rasmussen; E R Mathiesen; T Deckert; J Giese; N J Christensen; L Bent-Hansen; M D Nielsen
Journal:  Diabetologia       Date:  1987-08       Impact factor: 10.122

6.  Insulin induces upregulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms.

Authors:  G Nickenig; J Röling; K Strehlow; P Schnabel; M Böhm
Journal:  Circulation       Date:  1998-12-01       Impact factor: 29.690

7.  Salt sensitive human hypertension.

Authors:  M H Weinberger
Journal:  Endocr Res       Date:  1991       Impact factor: 1.720

8.  Thiazolidinediones suppress endothelin-1 secretion from bovine vascular endothelial cells: a new possible role of PPARgamma on vascular endothelial function.

Authors:  H Satoh; K Tsukamoto; Y Hashimoto; N Hashimoto; M Togo; M Hara; H Maekawa; N Isoo; S Kimura; T Watanabe
Journal:  Biochem Biophys Res Commun       Date:  1999-01-27       Impact factor: 3.575

9.  Negative regulation of rho signaling by insulin and its impact on actin cytoskeleton organization in vascular smooth muscle cells: role of nitric oxide and cyclic guanosine monophosphate signaling pathways.

Authors:  Najma Begum; Oana A Sandu; Noreen Duddy
Journal:  Diabetes       Date:  2002-07       Impact factor: 9.461

10.  Insulin-like growth factor I diminishes in vivo and in vitro vascular contractility: role of vascular nitric oxide.

Authors:  M F Walsh; M Barazi; G Pete; R Muniyappa; J C Dunbar; J R Sowers
Journal:  Endocrinology       Date:  1996-05       Impact factor: 4.736
View more
  11 in total

Review 1.  Metabolic safety of antihypertensive drugs: myth versus reality.

Authors:  Sameer Stas; Lama Appesh; James Sowers
Journal:  Curr Hypertens Rep       Date:  2006-10       Impact factor: 5.369

2.  Activation of prostaglandin E2 EP1 receptor increases arteriolar tone and blood pressure in mice with type 2 diabetes.

Authors:  Ibolya Rutkai; Attila Feher; Nora Erdei; Daniel Henrion; Zoltan Papp; Istvan Edes; Akos Koller; Gabor Kaley; Zsolt Bagi
Journal:  Cardiovasc Res       Date:  2009-03-19       Impact factor: 10.787

3.  Renin-angiotensin-aldosterone system in insulin resistance and metabolic syndrome.

Authors:  Undurti N Das
Journal:  J Transl Int Med       Date:  2016-07-07

4.  Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes.

Authors:  K Huynh; H Kiriazis; X-J Du; J E Love; K A Jandeleit-Dahm; J M Forbes; J R McMullen; R H Ritchie
Journal:  Diabetologia       Date:  2012-02-29       Impact factor: 10.122

5.  Apelin gene transfer into the rostral ventrolateral medulla induces chronic blood pressure elevation in normotensive rats.

Authors:  Qi Zhang; Fanrong Yao; Mohan K Raizada; Stephen T O'Rourke; Chengwen Sun
Journal:  Circ Res       Date:  2009-05-14       Impact factor: 17.367

6.  Hypertension and disrupted blood pressure circadian rhythm in type 2 diabetic db/db mice.

Authors:  Wen Su; Zhenheng Guo; David C Randall; Lisa Cassis; David R Brown; Ming C Gong
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-08-15       Impact factor: 4.733

7.  Aldosterone and hypertension in the cardiometabolic syndrome.

Authors:  Sameer Stas; Adam T Whaley-Connell; James R Sowers
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-02       Impact factor: 3.738

8.  The metabolic syndrome and mind-body therapies: a systematic review.

Authors:  Joel G Anderson; Ann Gill Taylor
Journal:  J Nutr Metab       Date:  2011-05-18

9.  Analysis of renin-angiotensin aldosterone system gene polymorphisms in Malaysian essential hypertensive and type 2 diabetic subjects.

Authors:  Vasudevan Ramachandran; Patimah Ismail; Johnson Stanslas; Norashikin Shamsudin
Journal:  Cardiovasc Diabetol       Date:  2009-02-25       Impact factor: 9.951

10.  The influence of yoga-based programs on risk profiles in adults with type 2 diabetes mellitus: a systematic review.

Authors:  Kim E Innes; Heather K Vincent
Journal:  Evid Based Complement Alternat Med       Date:  2007-12       Impact factor: 2.629
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.